title: Male breast uptake in rubidium-82 PET due to spironolactone-induced gynecomastia.
authors.affiliation: Department of Cardiology, Cleveland Clinic, Cleveland, OH, USA. kiehle@ccf.org.
authors.forename: E L
authors.initials: EL
authors.lastname: Kiehl
authors.affiliation: Department of Cardiology, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Shivapour
authors.affiliation: Department of Radiology, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: A H
authors.initials: AH
authors.lastname: Goenka
authors.affiliation: Department of Cardiology, Cleveland Clinic, Cleveland, OH, USA. jaberw@ccf.org.
authors.forename: W A
authors.initials: WA
authors.lastname: Jaber
mesh_terms: D000369:Aged, 80 and over; D001940:Breast / Q000000981:diagnostic imaging* / Q000187:drug effects; D018567:Breast Neoplasms, Male / Q000175:diagnosis; D003937:Diagnosis, Differential; D005355:Fibrosis / Q000000981:diagnostic imaging; D006177:Gynecomastia / Q000139:chemically induced* / Q000175:diagnosis / Q000000981:diagnostic imaging*; D006333:Heart Failure; D006801:Humans; D008297:Male; D049268:Positron-Emission Tomography; D012414:Rubidium Radioisotopes / Q000737:chemistry*; D013148:Spironolactone / Q000009:adverse effects / Q000737:chemistry*; D013599:Systole; D055114:X-Ray Microtomography
chemical_list: D012414:Rubidium Radioisotopes; D013148:Spironolactone